Evidence map›Paper›PMID 29368135›Full record

ArticleArchives of dermatological research2018

Phenotyping acute and chronic atopic dermatitis-like lesions in Stat6VT mice identifies a role for IL-33 in disease pathogenesis.

Sonia C DaSilva-Arnold, Anita Thyagarajan, Leroy J Seymour, Qiaofang Yi, Joshua R Bradish, Mohammed Al-Hassani, Hongming Zhou, Nikolajs J Perdue, Val Nemeth, Aleksandar Krbanjevic and 6 more

Abstract read
In one paragraph

Article in Archives of dermatological research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. IL-33 and IL-37: A Possible Axis in Skin and Allergic Diseases.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Sonia C DaSilva-ArnoldDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Anita ThyagarajanDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Leroy J SeymourDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Qiaofang YiDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Joshua R BradishDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Mohammed Al-HassaniDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Hongming ZhouDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Nikolajs J PerdueDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Val NemethDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Aleksandar KrbanjevicDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Ana P M SerezaniDepartment of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Matthew R OlsonDepartment of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Dan F SpandauDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Jeffrey B TraversDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Mark H KaplanDepartment of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Matthew J TurnerDepartment of Dermatology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. Turner41@iu.edu.ORCID http://orcid.org/0000-0002-5394-0923
Indiana University School of MedicineRichard L. Roudebush VA Medical Center · US

Funding

KOMP2-Phase3 Production and Phenotyping by the DTCC Consortium TCP Transfer to UC DavisUM1OD023221 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2016 to 2026
$45.7M
Platelet Activating Factor and Epidermic CytotoxicityR01HL062996 · NHLBI · WRIGHT STATE UNIVERSITY · PI TRAVERS, JEFFREY B. · 1999 to 2023
$7.2M
Cytokine regulation of skin barrier functionR01AI095282 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPLAN, MARK H · 2012 to 2022
$4.3M
Wounding Therapy and PhotocarcinogenesisR01AG048946 · NIA · WRIGHT STATE UNIVERSITY · PI SPANDAU, DAN F, TRAVERS, JEFFREY B. · 2014 to 2024
$2.9M
Mechanisms of photocarcinogenesis in geriatric skinR01ES020866 · NIEHS · INDIANA UNIVERSITY INDIANAPOLIS · PI SPANDAU, DAN F, TRAVERS, JEFFREY B. · 2012 to 2016
$1.7M
The Indiana Cutaneous Biological Research Training ProgramT32AR062495 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI ANDROPHY, ELLIOT J. · 2013 to 2017
$649k
Oxidized Lipids and UV ImmunosuppressionI01BX000853 · VA · RLR VA MEDICAL CENTER · PI Jeffrey B. Travers · 2011 to 2026
–
Role of keratinocyte-derived cytokines in epidermal injury and atopic dermatitisIK2CX001019 · VA · RLR VA MEDICAL CENTER · PI TURNER, MATTHEW J · 2016 to 2021
–
BLRD VA I01 BX000853CSRD VA I01 CX001956CSRD VA IK2 CX001019Dermatology Foundation Physician Scientist Career Development AwardNHLBI NIH HHS HL062996NHLBI NIH HHS R01 HL062996NIAID NIH HHS R01 AI095282NIAMS NIH HHS T32 AR062495NIA NIH HHS AG048946NIA NIH HHS R01 AG048946NIEHS NIH HHS ES020866NIEHS NIH HHS R01 ES020866NIH HHS UM1 OD023221Ralph W. and Grace M. Showalter Research Trust Fund (US) Showalter Young Investigator Award
6 · The paper itself

Abstract

The Stat6VT mouse model of atopic dermatitis (AD) is induced by T-cell-specific expression of a constitutively active form of the protein signal transducer and activator of transcription 6 (STAT6). Although AD-like lesions are known to develop in Stat6VT mice, this study was designed to determine if these mice develop acute and chronic phases of disease similar to humans. To address this, AD-like lesions from Stat6VT mice were harvested at two different timepoints relative to their onset. Lesions harvested within 1 week after development were defined as acute lesions, and those present for 1 month or more were defined as chronic lesions. Acute and chronic AD-like lesions from Stat6VT mice exhibited histologic findings and cytokine expression patterns similar to acute and chronic AD lesions in humans. Further analysis revealed increased levels of interleukin (IL)-33 transcripts in AD-like lesions compared to Stat6VT nonlesional and wild-type skin controls. Immunofluorescence also revealed increased numbers of IL-33

Indexed as

AnimalsDermatitis, AtopicDisease Models, AnimalInflammationInterleukin-33Keratin-15KeratinocytesMiceMice, Inbred C57BLMice, KnockoutSkinSTAT6 Transcription FactorTh1 CellsTh2 CellsIl33 protein, mouseInterleukin-33Keratin-15Krt15 protein, mouseStat6 protein, mouseSTAT6 Transcription FactorAtopic dermatitisEczemaInterleukin 33 (IL-33)KeratinocytesStat6VT transgenic mouse

Identifiers

PMID29368135
PMCPMC6198812
OpenAlexW2789232815

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.